These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25229199)

  • 1. Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice.
    Takahashi Y; Soejima Y; Kumagai A; Watanabe M; Uozaki H; Fukusato T
    Pathol Int; 2014 Oct; 64(10):490-8. PubMed ID: 25229199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice.
    Takahashi Y; Soejima Y; Kumagai A; Watanabe M; Uozaki H; Fukusato T
    PLoS One; 2014; 9(1):e87279. PubMed ID: 24466347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
    Cheng Y; Chen T; Ping J; Chen J
    Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet].
    Bian DX; Liu J; Lu L; Liu H; Guo JC; Yang WJ; Liu YL; Luo Y; Zhuang ZJ; Chen JY; Shi JP; Xun YH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):328-31. PubMed ID: 24645314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.
    Farrell GC; Mridha AR; Yeh MM; Arsov T; Van Rooyen DM; Brooling J; Nguyen T; Heydet D; Delghingaro-Augusto V; Nolan CJ; Shackel NA; McLennan SV; Teoh NC; Larter CZ
    Liver Int; 2014 Aug; 34(7):1084-93. PubMed ID: 24107103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet.
    de Lima VM; de Oliveira CP; Sawada LY; Barbeiro HV; de Mello ES; Soriano FG; Alves VA; Caldwell SH; Carrilho FJ
    Liver Int; 2007 Mar; 27(2):227-34. PubMed ID: 17311618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice.
    Ono M; Ogasawara M; Hirose A; Mogami S; Ootake N; Aritake K; Higuchi T; Okamoto N; Sakamoto S; Yamamoto M; Urade Y; Saibara T; Oben JA
    J Gastroenterol; 2014 Jun; 49(6):1065-73. PubMed ID: 23800945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low ethanol consumption on nonalcoholic steatohepatitis in mice.
    Takahashi Y; Watabe S; Togashi-Kumagai A; Watanabe M; Dungubat E; Kusano H; Kobayashi Y; Harada N; Yamaji R; Sugimoto K; Fukusato T
    Alcohol; 2020 Sep; 87():51-61. PubMed ID: 32553943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
    Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.
    Atarashi M; Izawa T; Miyagi R; Ohji S; Hashimoto A; Kuwamura M; Yamate J
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29401710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis.
    Kawaguchi T; Itou M; Taniguchi E; Sata M
    Int J Mol Med; 2014 Sep; 34(3):782-7. PubMed ID: 24993337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.